[go: up one dir, main page]

JPS6230965B2 - - Google Patents

Info

Publication number
JPS6230965B2
JPS6230965B2 JP56175168A JP17516881A JPS6230965B2 JP S6230965 B2 JPS6230965 B2 JP S6230965B2 JP 56175168 A JP56175168 A JP 56175168A JP 17516881 A JP17516881 A JP 17516881A JP S6230965 B2 JPS6230965 B2 JP S6230965B2
Authority
JP
Japan
Prior art keywords
drug
poorly soluble
pharmaceutical composition
water
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56175168A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5877810A (ja
Inventor
Akira Akazawa
Shimesu Motoyama
Satoru Sato
Seiichi Umeda
Hirotsune Yasumi
Emiko Sudo
Takuichi Tsujino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUROINTO SANGYO KK
Original Assignee
FUROINTO SANGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUROINTO SANGYO KK filed Critical FUROINTO SANGYO KK
Priority to JP17516881A priority Critical patent/JPS5877810A/ja
Priority to DE19823224619 priority patent/DE3224619A1/de
Priority to CH4123/82A priority patent/CH652307A5/de
Priority to KR8203134A priority patent/KR880000970B1/ko
Publication of JPS5877810A publication Critical patent/JPS5877810A/ja
Priority to US06/724,502 priority patent/US4751241A/en
Publication of JPS6230965B2 publication Critical patent/JPS6230965B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
JP17516881A 1981-07-14 1981-11-01 ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物 Granted JPS5877810A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP17516881A JPS5877810A (ja) 1981-11-01 1981-11-01 ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物
DE19823224619 DE3224619A1 (de) 1981-07-14 1982-07-01 Orale pharmazeutische zusammensetzung
CH4123/82A CH652307A5 (de) 1981-07-14 1982-07-06 Pharmazeutische zusammensetzung fuer die orale anwendung.
KR8203134A KR880000970B1 (ko) 1981-07-14 1982-07-14 생물학적 유용성이 높은 경구용 약학적 조성물의 제조방법
US06/724,502 US4751241A (en) 1981-07-14 1985-04-19 Pharmaceutical composition of cyclandelate having a high degree of bioavailability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17516881A JPS5877810A (ja) 1981-11-01 1981-11-01 ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物

Publications (2)

Publication Number Publication Date
JPS5877810A JPS5877810A (ja) 1983-05-11
JPS6230965B2 true JPS6230965B2 (no) 1987-07-06

Family

ID=15991447

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17516881A Granted JPS5877810A (ja) 1981-07-14 1981-11-01 ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物

Country Status (1)

Country Link
JP (1) JPS5877810A (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0665645B2 (ja) * 1985-09-18 1994-08-24 日清製粉株式会社 自己乳化型軟カプセル薬液
CN1053570C (zh) * 1987-10-07 2000-06-21 默尔多药物公司 哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
AR240018A1 (es) * 1987-10-07 1990-01-31 Merrell Pharma Inc Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
JPH01128921A (ja) * 1987-11-12 1989-05-22 Taisho Pharmaceut Co Ltd ビタミンｅの吸収促進製剤
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
JP4567945B2 (ja) * 2003-01-17 2010-10-27 太陽化学株式会社 ユビデカレノン製剤
CA2520660C (en) * 2003-03-28 2013-08-20 Sigmoid Biotechnologies Limited Solid oral dosage form containing seamless microcapsules
JP2005126414A (ja) * 2003-09-11 2005-05-19 Kiyotoshi Oshiro 吸収を高める生薬成分含有組成物及びその製造方法。
CN101119710B (zh) * 2004-11-16 2013-03-27 生物利用股份有限公司 用于营养用途的高浓度自微乳化辅酶q10制剂
JP5128801B2 (ja) 2006-10-16 2013-01-23 フロイント産業株式会社 高水分散性粉末とその製造方法
JP5154805B2 (ja) * 2007-01-26 2013-02-27 江崎グリコ株式会社 分散ヘスペレチン
JP5553747B2 (ja) 2007-04-04 2014-07-16 シグモイド・ファーマ・リミテッド シクロスポリン医薬組成物
JP5203084B2 (ja) * 2008-07-30 2013-06-05 江崎グリコ株式会社 分散ヘスペレチン
PL2471518T3 (pl) 2009-05-18 2018-01-31 Sigmoid Pharma Ltd Kompozycja zawierająca kropelki oleju
IN2012DN00781A (no) 2009-08-12 2015-06-26 Sigmoid Pharma Ltd
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
PL3215127T3 (pl) 2014-11-07 2021-05-17 Sublimity Therapeutics Limited Kompozycje zawierające cyklosporynę

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3495011A (en) * 1968-10-28 1970-02-10 Unimed Inc Reduction of blood level cholesterol
JPS4971127A (no) * 1972-11-18 1974-07-10
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations
JPS5581813A (en) * 1978-12-16 1980-06-20 Nisshin Flour Milling Co Ltd Composition containing coenzyme q10 and its perparation
JPS55115820A (en) * 1979-02-27 1980-09-06 Nippon Shoji Kk High-purity phospholipid capsule preparation

Also Published As

Publication number Publication date
JPS5877810A (ja) 1983-05-11

Similar Documents

Publication Publication Date Title
JPH0474339B2 (no)
KR880000970B1 (ko) 생물학적 유용성이 높은 경구용 약학적 조성물의 제조방법
CA2193497C (en) Controlled release aqueous emulsion
JPS6230965B2 (no)
ES2226976T3 (es) Formulaciones galenicas de fenofibrato y su procedimiento de obtencion.
US20020102301A1 (en) Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
JP2006511536A (ja) 水貧溶性薬物のバイオアベイラビリティーを改善する自由流動性固形製剤およびその製造方法
AU2019329905B2 (en) Vitamin D pediatric dosage forms, methods of making and using
JP2022549729A (ja) 酢酸アビラテロンを含む医薬組成物、並びにその製造方法及び使用
EP0985411B1 (en) Sterol esters in tableted solid dosage forms
WO2006021160A1 (fr) Système de relargage de médicament auto-émulsifiant à base de butylbenzènephtaléine, méthode de préparation et applications d’un tel système
CN112353845B (zh) 含中药挥发油的热熔挤出组合物及其制备方法和药物制剂
JPH0354926B2 (no)
JPH0115A (ja) 吸収改善製剤
AU2003220643B2 (en) Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
WO2021151168A1 (en) Method of cannabinoid therapy
AU4445901A (en) Bioavailable dosage form of isotretinoin
JPS6351122B2 (no)
TW202128150A (zh) ３＇—［（２ｚ）—［１—（３，４—二甲基苯基）—１，５—二氫—３—甲基—５—側氧基—４ｈ—吡唑—４—亞基］肼基］—２＇—羥基—［１，１＇—聯苯基］—３—甲酸及其鹽配製物
WO2022195545A1 (en) Novel pharmaceutical formulations
CN118304279A (zh) 一种骨化三醇自微乳口溶膜及其制备方法
CN110496108A (zh) 用于非诺贝特的具有提高的溶出度的糯米纸囊制剂和胶囊制剂
MXPA99008044A (en) Sterol esters in solid dose forms as table